Implementation of Epilepsy Multigene Panel Testing in Ontario, Canada
- 30 October 2019
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 47 (1) , 61-68
Abstract
Background: Epilepsy is a common neurological condition that shows a marked genetic predisposition. The advent of next-generation sequencing (NGS) has transformed clinical genetic testing by allowing the rapid screen for causative variants in multiple genes. There are currently no NGS-based multigene panel diagnostic tests available for epilepsy as a licensed clinical diagnostic test in Ontario, Canada. Eligible patient samples are sent out of country for testing by commercial laboratories, which incurs significant cost to the public healthcare system.Objective: An expert Working Group of medical geneticists, pediatric neurologists/epileptologists, biochemical geneticists, and clinical molecular geneticists from Ontario was formed by the Laboratories and Genetics Branch of the Ontario Ministry of Health and Long-Term Care to develop a programmatic approach to implementing epilepsy panel testing as a provincial service.Results: The Working Group made several recommendations for testing to support the clinical delivery of care in Ontario. First, an extension of community healthcare outcomes-based program should be incorporated to inform and educate ordering providers when requesting and interpreting a genetic panel test. Second, any gene panel testing must be “evidence-based” and takes into account varied clinical indications to reduce the chance of uncertain and secondary results. Finally, an ongoing evaluative process was recommended to ensure continued test improvement for the future.Conclusion: This epilepsy panel testing implementation plan will be a model for genetic care directed toward a specific set of conditions in the province and serve as a prototype for genetic testing for other genetically heterogeneous diseases.Keywords
This publication has 16 references indexed in Scilit:
- The Exome Clinic and the role of medical genetics expertise in the interpretation of exome sequencing resultsGenetics in Medicine, 2017
- When Should Genetic Testing be Performed in Epilepsy Patients?Epilepsy Currents, 2017
- Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel AnalysisThe Journal of Molecular Diagnostics, 2016
- Review of Commercially Available Epilepsy Genetic PanelsJournal of Genetic Counseling, 2015
- ClinGen — The Clinical Genome ResourceNew England Journal of Medicine, 2015
- Diagnostic yield of genetic testing in epileptic encephalopathy in childhoodEpilepsia, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- The hidden genetics of epilepsy—a clinically important new paradigmNature Reviews Neurology, 2014
- Epilepsy Genetics Revolutionizes Clinical PracticeNeuropediatrics, 2014
- Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care ProvidersNew England Journal of Medicine, 2011